Concentration clarity, carrier compatibility, finished-product presentation, documentation, labeling accuracy, and storage expectations all matter
Freeze-exposed product is documented as outside the validated spec
External resources PubMed: AOD 9604 lipolytic activity study - Research on AOD 9604 mechanism of action in adipose tissue New England Journal of Medicine: STEP 1 Trial - Landmark semaglutide weight loss trial with 1,961 participants FDA: Semaglutide safety information - Official FDA information on approved semaglutide formulations WADA Prohibited List - Current prohibited substances list including growth hormone fragments ClinicalTrials.gov: Semaglutide trials - Registry of ongoing and completed semaglutide clinical trials Choosing between AOD 9604 and semaglutide is ultimately a decision that depends on your individual circumstances, health status, and weight loss goals
Better approach: use a 2mg vial for the first 4 weeks (1mg used, 1mg wasted)
Koniver reports results very close to BPC with no side effects observed
Applications include investigating sarcopenia prevention, athletic performance enhancement, and age-related muscle decline through stem cell pathway activation